GL1X · GenesisL1 explorer

MolNFT v1 · #46678 · protein

Discovery of the HCV NS3/4A protease inhibitor SCH503034. key steps in structure-based optimization

2OBQ · Hepatitis C virus: “Discovery of the HCV NS3/4A protease inhibitor SCH503034. key steps in structure-based optimization”. X-ray diffraction, 1 ligand (ZN), 3 pockets (best druggability 0.62). MolNFT v1 #46678 on GenesisL1: 3D…

PDB
2OBQ
Type
protein
Length
369 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatitis C virus
UniProt
Q9ELS8, P27958
Ligands
ZN
Pockets
3 · best druggability 0.62

Structure

x-ray diffraction · 4 distinct chains · 11% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatitis C virusprotein18014% helix, 44% strandQ9ELS8
BHepatitis C virusprotein220% helix, 45% strandP27958
CHepatitis C virusprotein15110% helix, 51% strandQ9ELS8
DHepatitis C virusprotein160% helix, 56% strandP27958

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1780.620.9019empty
21050.420.7721empty
3610.360.7816empty

Interfaces

6 interfaces between chains.

  • A–B · 1237 Ų buried · 32 hydrogen bonds · protein-protein
  • C–D · 856 Ų buried · 14 hydrogen bonds · protein-protein
  • A–C · 458 Ų buried · 4 hydrogen bonds · protein-protein
  • B–D · 313 Ų buried · 6 hydrogen bonds · protein-protein
  • B–C · 222 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 2OBQ · Discovery of the HCV NS3/4A Protease Inhibitor SCH503034. Key Steps in Structure-Based… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.